The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant atezolizumab (atezo) and nab-paclitaxel (nab-p) in patients (pts) with triple-negative breast cancer (TNBC) with suboptimal clinical response to doxorubicin and cyclophosphamide (AC).
 
Clinton Yam
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Merck (Inst)
 
Elizabeth A. Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Exact Sciences; Merck; Roche; Roche/Genentech
Research Funding - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Lilly
 
Ryan Sun
No Relationships to Disclose
 
Lei Huo
No Relationships to Disclose
 
Senthil Damodaran
Honoraria - Novartis
Research Funding - EMD Serono (Inst); Guardant Health (Inst); Novartis (Inst); Sermonix Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Phillips Gilmore Oncology Communications
 
Gaiane M Rauch
No Relationships to Disclose
 
Rosalind P Candelaria
No Relationships to Disclose
 
Beatriz E Adrada
No Relationships to Disclose
 
Sahil Seth
No Relationships to Disclose
 
William Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; Eiger BioPharmaceuticals; ISIS Pharmaceuticals; Nuvera Biosciences
Consulting or Advisory Role - Almac Diagnostics; Merck
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
Travel, Accommodations, Expenses - Luminex; Merck
(OPTIONAL) Uncompensated Relationships - Delphi Diagnostics
 
Rashmi Krishna Murthy
Honoraria - AstraZeneca; Genentech; Novartis; Puma Biotechnology; Seagen
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Novartis; Puma Biotechnology; Seagen
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genentech; Seagen
 
Jason B White
Patents, Royalties, Other Intellectual Property - Two patents pending at AstraZeneca/Medimmune related to antibody-drug conjugate technology.
 
Elizabeth Ravenberg
No Relationships to Disclose
 
Alyson Clayborn
No Relationships to Disclose
 
Sabitha Prabhakaran
No Relationships to Disclose
 
Vicente Valero
Honoraria - Genentech/Roche; Merck; Novartis
Consulting or Advisory Role - Genentech/Roche; Merck; Novartis
Travel, Accommodations, Expenses - Genentech/Roche
 
Alastair Mark Thompson
No Relationships to Disclose
 
Debu Tripathy
Consulting or Advisory Role - AstraZeneca; Genomic Health; GlaxoSmithKline; Novartis; OncoPep; Pfizer
Research Funding - Novartis (Inst); Polyphor (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Stacy L. Moulder
Research Funding - Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Novartis (Inst); Pfizer (Inst)
 
Jennifer Keating Litton
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Medivation/Pfizer; Pfizer
Speakers' Bureau - Clinical Care Options; Med Learning Group; Medpage; Medscape; Physicans' Education Resource; Prime Oncology; UpToDate
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Genentech (Inst); pfizer (Inst); Zenith Epigenetics (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Clinical Care Options; Med Learning Group; Medscape; Physicans' Education Resource
Other Relationship - Medivation/Pfizer